Search research articles
Contact Us
Filters
Showing results (111-120 of 317) with videos related to
Page
of 32
Sort By:
International Archives of Allergy and Immunology
|
March 28, 2008
Evaluation of an in vitro mast cell degranulation test in the context of food allergy to wheat
M Bodinier, C Brossard, S Triballeau, et al.
Current Oncology (Toronto, Ont.)
|
December 23, 2021
Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors
Christian U Blank, Deborah J Wong, Thai H Ho, et al.
European Journal of Clinical Pharmacology
|
September 3, 2013
The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand-foot syndrome
Nienke A G Lankheet, Alwin D R Huitema, Henk Mallo, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 3, 2016
Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
M K van der Kooij, A Joosse, F M Speetjens, et al.
Journal for Immunotherapy of Cancer
|
May 13, 2026
Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?
Marije A Strikwerda, Lotte L Hoeijmakers, Sophie P G R Veenstra, et al.
European Journal of Immunology
|
February 14, 2023
Acidity-mediated induction of FoxP3<sup>+</sup> regulatory T cells
Disha Rao, Johanna A Stunnenberg, Ruben Lacroix, et al.
Cancer Treatment Reviews
|
November 1, 2024
Local administration of immunotherapy for patients with skin cancer: A systematic review
J C Janssen, B van Dijk, L L Hoeijmakers, et al.
Cancer Immunology, Immunotherapy : CII
|
June 25, 2015
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma
Aurelie Guislain, Jules Gadiot, Andrew Kaiser, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2025
Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitors
E A C Albers, M J Luijendijk, M Egeler, et al.
Nature
|
October 5, 2017
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
Xiangjun Kong, Thomas Kuilman, Aida Shahrabi, et al.
Page
of 32
Search research articles
Search
Showing results (111-120 of 317) with videos related to
Sort By:
Page
of 32
International Archives of Allergy and Immunology
|
March 28, 2008
Evaluation of an in vitro mast cell degranulation test in the context of food allergy to wheat
M Bodinier, C Brossard, S Triballeau, et al.
Current Oncology (Toronto, Ont.)
|
December 23, 2021
Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors
Christian U Blank, Deborah J Wong, Thai H Ho, et al.
European Journal of Clinical Pharmacology
|
September 3, 2013
The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand-foot syndrome
Nienke A G Lankheet, Alwin D R Huitema, Henk Mallo, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 3, 2016
Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
M K van der Kooij, A Joosse, F M Speetjens, et al.
Journal for Immunotherapy of Cancer
|
May 13, 2026
Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?
Marije A Strikwerda, Lotte L Hoeijmakers, Sophie P G R Veenstra, et al.
European Journal of Immunology
|
February 14, 2023
Acidity-mediated induction of FoxP3<sup>+</sup> regulatory T cells
Disha Rao, Johanna A Stunnenberg, Ruben Lacroix, et al.
Cancer Treatment Reviews
|
November 1, 2024
Local administration of immunotherapy for patients with skin cancer: A systematic review
J C Janssen, B van Dijk, L L Hoeijmakers, et al.
Cancer Immunology, Immunotherapy : CII
|
June 25, 2015
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma
Aurelie Guislain, Jules Gadiot, Andrew Kaiser, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2025
Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitors
E A C Albers, M J Luijendijk, M Egeler, et al.
Nature
|
October 5, 2017
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
Xiangjun Kong, Thomas Kuilman, Aida Shahrabi, et al.
Page
of 32